Japanese Biotech Stock News

TSE:4523
TSE:4523Pharmaceuticals

Does Strong Lecanemab Treatment Persistence Reshape The Bull Case For Eisai (TSE:4523)?

Eisai and its partners recently reported real-world data at the AD/PD 2026 conference showing that most early Alzheimer’s patients in the U.S. remained on intravenous lecanemab beyond 18 months, with persistence still above two-thirds at 24 months, broadly aligning with outcomes seen in the Phase 3 Clarity AD trial and its long-term extension. The new findings, alongside expanding approvals and filings for more convenient maintenance and subcutaneous lecanemab dosing, reinforce the therapy’s...
TSE:1605
TSE:1605Oil and Gas

Assessing Inpex (TSE:1605) After Beetaloo Basin Joint Venture Signals Long Term LNG Growth Potential

Formentera Partners and Inpex (TSE:1605) have agreed to a joint venture focused on developing natural gas resources in Australia’s onshore Beetaloo Basin, including a staged acreage earn in and planned LNG export support. See our latest analysis for Inpex. The joint venture headlines arrive as momentum in Inpex’s shares has been strong, with a 1 month share price return of 28.95% and a year to date share price return of 57.25%. The 1 year total shareholder return of 141.57% points to...
TSE:3923
TSE:3923Software

High Growth Tech Stocks in Asia for March 2026

The Asian markets have been navigating a complex landscape marked by energy price volatility and geopolitical tensions, with these factors significantly influencing investor sentiment and economic outlooks across the region. Amidst this backdrop, high growth tech stocks in Asia are drawing attention for their potential to offer robust returns despite broader market uncertainties. In such an environment, a good stock is often characterized by strong fundamentals, resilience to external shocks...
TSE:6787
TSE:6787Electronic

Asian Growth Leaders With High Insider Ownership March 2026

In the wake of geopolitical tensions and energy price volatility impacting global markets, Asian equities have experienced mixed performance, with investor sentiment swayed by external pressures and regional economic responses. Amidst these challenges, growth companies with high insider ownership in Asia stand out as potentially resilient options, as such ownership can align management interests with shareholder value during uncertain times.
TSE:3697
TSE:3697IT

Is SHIFT’s New Secure One Subsidiary Reframing Its Security‑First Strategy For SHIFT (TSE:3697)?

On March 24, 2026, SHIFT Inc.’s board approved the past decision to incorporate Secure One Co. Ltd. in Tokyo as a wholly owned subsidiary focused on security services, including vulnerability assessments, with planned share capital of ¥10,000,000 and overlapping directors and auditor from SHIFT. The creation of Secure One alongside planned mergers among existing subsidiaries points to a tighter, security‑centric group structure and closer internal service integration between SHIFT and its...
TSE:3086
TSE:3086Multiline Retail

How February’s 13.2% Sales Jump Will Impact J. Front Retailing (TSE:3086) Investors

In March 2026, J. Front Retailing Co., Ltd. reported that its consolidated sales for February rose 13.2%, with year‑to‑date sales up 3.2%. This acceleration in monthly and year‑to‑date sales offers a fresh data point on how the group’s renovation, inbound and content initiatives may be resonating with customers. With February’s strong 13.2% consolidated sales growth as a backdrop, we’ll now examine how this update influences J. Front Retailing’s investment narrative. Invest in the nuclear...
TSE:8795
TSE:8795Insurance

T&D Holdings (TSE:8795) Is Up 7.6% After Raising Revenue Outlook And Lifting Dividend Target

In March 2026, T&D Holdings, Inc. raised its fiscal 2026 ordinary revenue forecast to ¥3.42 trillion and lifted expected earnings per share to ¥237.45, citing stronger-than-anticipated insurance premium income from higher sales of single premium products, while leaving profit guidance unchanged. The company also increased its year-end dividend guidance to ¥68 per share and introduced a new policy targeting cash dividends of about 60% of five-year average Group adjusted profit, signaling a...
TSE:7004
TSE:7004Machinery

Kanadevia (TSE:7004) Valuation In Focus As Board Weighs Subsidiary Share Transfer

Board meeting puts Kanadevia’s group structure in focus Kanadevia (TSE:7004) has called a board meeting for March 26, 2026, to review and approve a potential share transfer involving a consolidated subsidiary, bringing attention to how any change might affect the wider group. See our latest analysis for Kanadevia. The upcoming board meeting lands after a mixed period for the stock, with a 7.92% year to date share price return and a 10.11% one year total shareholder return suggesting that...
TSE:9369
TSE:9369Logistics

K.R.S (TSE:9369) Margin Slippage To 1.3% Tests Bullish Earnings Narratives

K.R.S (TSE:9369) has opened Q1 2026 with revenue of ¥50.1b and basic EPS of ¥23.58, alongside trailing 12 month EPS of ¥106.09 on revenue of ¥204.2b. This keeps the earnings profile in focus for anyone watching margin resilience. The company has seen quarterly revenue move from ¥48.5b in Q1 2025 through ¥51.9b in Q4 2025 to ¥50.1b in the latest quarter, while basic EPS has ranged from ¥24.02 to ¥35.00 over that period. This sets up this release as a check on how much profit the business can...
TSE:6963
TSE:6963Semiconductor

A Look At ROHM (TSE:6963) Valuation After A 119.12% One Year Shareholder Return

Recent share performance and earnings snapshot Without a single headline event driving attention, ROHM (TSE:6963) has still been on many investors’ radars after a 44.64% return over the past 3 months and a 12 month total return of 119.12%. That share performance sits alongside annual revenue of ¥473,339.0 and a reported net income loss of ¥35,478.0. This presents a mixed picture of growth and profitability to weigh when assessing the stock. See our latest analysis for ROHM. The 12 month total...
TSE:4704
TSE:4704Software

Trend Micro (TSE:4704) Valuation Check After Launch Of TrendAI Agentic Governance Gateway

Trend Micro (TSE:4704) is back in focus after unveiling its TrendAI Agentic Governance Gateway, a product aimed at securing autonomous AI agents across complex workflows, following research that underscores rising AI adoption despite unresolved risk controls. See our latest analysis for Trend Micro. The new AI security launches sit against mixed recent trading, with the share price at ¥5,338 after a 2.32% 1 day share price return, a 21.11% 90 day share price decline, and a 46.82% 1 year total...
TSE:8361
TSE:8361Banks

A Look At Ogaki Kyoritsu Bank’s Valuation As Treasury Share Cancellation Is Considered

Board meeting and treasury share cancellation Ogaki Kyoritsu Bank (TSE:8361) has scheduled a March 25, 2026 board meeting to consider cancelling treasury shares under Article 178 of the Companies Act, an action that would reduce outstanding shares. See our latest analysis for Ogaki Kyoritsu Bank. The planned treasury share cancellation comes after a strong period for investors, with Ogaki Kyoritsu Bank’s 90 day share price return of 33.76% and a 1 year total shareholder return of 160.42%...
TSE:7951
TSE:7951Leisure

Yamaha (TSE:7951) Valuation Check As Mixed Returns Contrast With DCF Upside Potential

Yamaha’s recent performance snapshot With no single event driving headlines, Yamaha (TSE:7951) has still given investors plenty to think about, from recent share price moves to its mix of musical instruments, audio equipment and other businesses. The stock’s return over the past month reflects some pullback compared with the past 3 months, and the past year has also been weaker, even as annual revenue and net income figures of ¥452,404 and ¥19,252 indicate a sizeable, diversified...
TSE:4568
TSE:4568Pharmaceuticals

Daiichi Sankyo (TSE:4568) Valuation After New Tempus AI Partnership In Antibody Drug Conjugate Oncology

Daiichi Sankyo Company (TSE:4568) shares are in focus after a new collaboration with Tempus AI to apply foundation models and real-world oncology data to an antibody drug conjugate program. See our latest analysis for Daiichi Sankyo Company. The AI collaborations, ENHERTU approval in Japan and completion of the latest buyback tranche come as the share price trades at ¥2,930 following a 1 day share price return of 1.93%. However, the 1 year total shareholder return of 19.20% and 3 year total...
TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical TSE 4502 Valuation Check After Positive Zasocitinib Phase 3 Psoriasis Data

Takeda Pharmaceutical (TSE:4502) is back in focus after releasing new Phase 3 data for its investigational TYK2 inhibitor zasocitinib in moderate to severe plaque psoriasis, paired with plans for future regulatory filings. See our latest analysis for Takeda Pharmaceutical. The zasocitinib data appear to have arrived during a strong run for the shares, with a 90-day share price return of 19.92% and a 1-year total shareholder return of 33.75% suggesting momentum has been building over both...
TSE:2768
TSE:2768Trade Distributors

Sojitz Taps Predictive Health Testing To Broaden Asia Pacific Growth Story

Sojitz group company Royal Healthcare in Singapore has begun offering NEC Corporation's FonesVisuas Test, an advanced blood test that estimates the risk of multiple diseases. This marks Sojitz's entry into predictive health testing in Southeast Asia through its partnership with NEC and Royal Healthcare. The move expands Sojitz's presence in healthcare, adding a new dimension to its business portfolio in the Asia Pacific region. For investors tracking Sojitz (TSE:2768), this development adds...
TSE:8088
TSE:8088Oil and Gas

A Look At Iwatani (TSE:8088) Valuation After The CEO Transition To Hiroshi Majima

Iwatani (TSE:8088) is drawing fresh attention after announcing a CEO transition, with Akiji Makino moving to the role of Chairman and Hiroshi Majima becoming President and CEO on April 1, 2026. See our latest analysis for Iwatani. The CEO transition comes as Iwatani’s share price has shown firm momentum, with a 25.4% 90 day share price return and a 37.8% 1 year total shareholder return from a latest close of ¥2,066.5. If this leadership change has you thinking more broadly about opportunities...
TSE:8952
TSE:8952Office REITs

Assessing Japan Real Estate Investment (TSE:8952) Valuation After Raised Guidance And Follow On Equity Offering

Japan Real Estate Investment (TSE:8952) lifted its earnings and dividend guidance after agreeing to acquire additional office assets in Tokyo and Sapporo, alongside filing a follow on equity offering to fund this expanded portfolio. See our latest analysis for Japan Real Estate Investment. At a share price of ¥122,200, Japan Real Estate Investment has a 1-year total shareholder return of 14.65%. This is even though the 30-day share price return of 7.63% and the year-to-date share price return...
TSE:9104
TSE:9104Shipping

Assessing Mitsui O.S.K. Lines (TSE:9104) Valuation After Elliott’s Undervaluation Call And Recent Share Price Momentum

Elliott Investment Management’s new statement on Mitsui O.S.K. Lines (TSE:9104) has pushed investor attention toward the company’s upcoming medium term management plan and the question of how the market values its shipping assets. See our latest analysis for Mitsui O.S.K. Lines. The Elliott statement lands after a strong run in the share price, with a 30 day share price return of 23.39% and a 90 day share price return of 51.93%. The 5 year total shareholder return of roughly 7x signals that...
TSE:9336
TSE:9336Commercial Services

Assessing Daiei Kankyo (TSE:9336) Valuation After New 2027 Earnings Guidance And Growth Drivers

Guidance update and why it matters for Daiei Kankyo (TSE:9336) Daiei Kankyo (TSE:9336) drew investor attention after its March 24, 2026 board meeting, where the company approved new full year consolidated earnings forecasts for the fiscal year ending March 31, 2027. The guidance outlines expected net sales of ¥93,900 million, operating profit of ¥24,300 million and profit attributable to owners of parent of ¥15,000 million, with basic earnings per share projected at ¥150.23. See our latest...
TSE:9072
TSE:9072Transportation

A Look At NIKKON Holdings (TSE:9072) Valuation After Completing Its Share Buyback Program

NIKKON Holdings Ltd (TSE:9072) has wrapped up its share buyback program, repurchasing 4,227,100 shares, or 3.53% of its stock, for ¥14,999.86 million by March 24, 2026. See our latest analysis for NIKKON HoldingsLtd. The completion of the buyback comes during a strong run for the stock, with a 1 day share price return of 9.12% and a 90 day share price return of 54.18%. The 5 year total shareholder return is very large, indicating that momentum has been building rather than fading. If NIKKON's...
TSE:8035
TSE:8035Semiconductor

Assessing Tokyo Electron (TSE:8035) Valuation After Recent Share Price Pullback

Why Tokyo Electron Is On Investors’ Radar Now Tokyo Electron (TSE:8035) has drawn attention after a sharp month pullback of about 13%, even as its past 3 months return sits around 14%. That gap is prompting closer scrutiny from investors. See our latest analysis for Tokyo Electron. The recent 13% one-month share price pullback to about ¥39,290 comes after a 14% three-month share price return and a very strong one-year total shareholder return of 84%. This suggests that short-term momentum has...
TSE:6503
TSE:6503Electrical

Mitsubishi Electric Merger Talks Put Power Chip Valuation In Focus

Mitsubishi Electric, Toshiba and Rohm are reported to be in talks to merge their power semiconductor device operations. The potential combination would create a larger Japanese player in power chips, an area supported by government policy and global demand trends. The development is seen as a material shift for Mitsubishi Electric’s power device business and its competitive position in TSE:6503. Mitsubishi Electric, listed as TSE:6503, is entering these merger talks with a share price of...